Discontinued — last reported Q3 '24
Year-over-year, this metric grew by 300.0%, from $2.00M to $8.00M. This is a positive signal — higher values indicate stronger performance for this metric.
Higher additions signal strong business development success and continued interest from grant-awarding institutions in the company's technology.
This represents new grant funding commitments or increases to existing awards recognized during the reporting period. It...
Comparable to 'new bookings' or 'new contract wins' in service-based or project-based business models.
mrna_segment_grant_revenue_additions| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.00M | $10.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.00M | $0.00 | $0.00 | $0.00 | $8.00M |
| QoQ Change | — | +25.0% | -100.0% | — | — | — | — | — | — | -100.0% | — | — | — |
| YoY Change | — | — | — | -100.0% | -100.0% | — | — | — | — | — | — | — | +300.0% |